Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of abatacept (Orencia) on synovial tissue biomarkers in rheumatoid arthritis
2010-021435-14Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2010
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of abatacept in rheumatoid arthritis (RA), sponsored by Amsterdam University Medical Center. Primary endpoint: Change in synovial cell infiltrate and cytokine expression. Started Jun 2010; status: active.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-021435-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021435-14.